4[5]Hasik MJ,Kim DH,How le LE,et al.Evaluation of synthetic phospholip id ultrasound contrast agents[J].Ultrasonics,2002,40(9):973-982.
5[6]Morel DR,Schwieger I,Hohn L,et al.Hunan pharmacokinetics and safety evaluation of Sono Vue,a new contrast agent for ultrasound imaging[J].Inest Radiol,2000,35(1):80-85.
6[7]Bokor D,Chamhers JB,Rees PJ,et al.Clinical safety of SonoVue,a new contrast agent for ultrasound imaging,in healthy volunteers and in petients with chronic obstructive pulmvonary disease[J].Invest Radiol,2001,36(1):104-109.
8[9]Abramowicz JS.Ultrasonographic contrast media:Has the time come in obsterics and gynecology[J].J Ultrasound Med,2005,24(4):517-531.
9[10]Gultekin S,Yucel C,Ozdem ir H,et al.The role of late-phase lulse inversion harmonic imaging in the detection of occult hepatic metastases[J].J Ultrasound Med,2006,25(9):1139-1145.
8Porter T,Li S,Kilzer K,et al.Non-invasive prevention of lumen area narrowing following coronary balloon injury with intravenous antisense to the c-myc protooncogene bound to perfluorocarbon microbubbles[J].Circulation,1999,100(18 suppl 1): I-365.
9Price RJ,Skyba DM,Kaul S,et al.Delivery of colloidal particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound[J].Circulation,1998,98:1264-1267.
10Porter TR,Xie F,Lversen P,et al.Intravenous antisense administered bound to perfluorocarbon exposed sonicated dextrose albumin microbubbles inhibits stenosis formation following coronary balloon injury[J].Circulation,1998,98: I503(abstract).
9Schlosser T, Pohl C, Kuntz-Hehner S, et al. Echoscintigraphy: a new imaging modality for the reduction of colour blooming and acoustic shadowing in contrast sonography. Ultrasound Med Biol, 2003,29:985 - 991.
10Dekel Y, Koren R, Kugel V, et al. Significance of angiogenesis and microvascular invasion in renal cell carcinoma. Pathol Oncol Res, 2002,8 : 129 - 132.
